Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice—from a human poisoning case to the preclinical evidence.

Saved in:
Bibliographic Details
Title: Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice—from a human poisoning case to the preclinical evidence.
Authors: Bassi, Marta (AUTHOR), Bilel, Sabrine (AUTHOR), Tirri, Micaela (AUTHOR), Corli, Giorgia (AUTHOR), Di Rosa, Fabiana (AUTHOR), Gregori, Adolfo (AUTHOR), Alkilany, Alaaldin M. (AUTHOR), Rachid, Ousama (AUTHOR), Roda, Elisa (AUTHOR), Zauli, Giorgio (AUTHOR), Locatelli, Carlo Alessandro (AUTHOR), Marti, Matteo (AUTHOR)
Source: Psychopharmacology. Mar2024, Vol. 241 Issue 3, p489-511. 23p.
Subjects: Tryptamine, Neural inhibition, Hallucinogenic drugs, Poisoning, Psilocybin, Mice
Abstract: Rationale: The 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT, known online as "Moxy") is a new psychedelic tryptamine first identified on Italian national territory in 2014. Its hallucinogen effects are broadly well-known; however, only few information is available regarding its pharmaco-toxicological effects. Objectives: Following the seizure of this new psychoactive substances by the Arm of Carabinieri and the occurrence of a human intoxication case, in the current study we had the aim to characterize the in vivo acute effects of systemic administration of 5-MeO-MiPT (0.01–30 mg/kg i.p.) on sensorimotor (visual, acoustic, and overall tactile) responses, thermoregulation, and stimulated motor activity (drag and accelerod test) in CD-1 male mice. We also evaluated variation on sensory gating (PPI, prepulse inhibition; 0.01–10 mg/kg i.p.) and on cardiorespiratory parameters (MouseOx and BP-2000; 30 mg/kg i.p.). Lastly, we investigated the in silico ADMET (absorption, distribution, metabolism, excretion, toxicity) profile of 5-MeO-MiPT compared to 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) and N,N-dimethyltryptamine (DMT). Results: This study demonstrates that 5-MeO-MiPT dose-dependently inhibits sensorimotor and PPI responses and, at high doses, induces impairment of the stimulated motor activity and cardiorespiratory changes in mice. In silico prediction shows that the 5-MeO-MiPT toxicokinetic profile shares similarities with 5-MeO-DIPT and DMT and highlights a cytochrome risk associated with this compound. Conclusions: Consumption of 5-MeO-MiPT can affect the ability to perform activities and pose a risk to human health status, as the correspondence between the effects induced in mice and the symptoms occurred in the intoxication case suggests. However, our findings suggest that 5-MeO-MiPT should not be excluded from research in the psychiatric therapy field. [ABSTRACT FROM AUTHOR]
Copyright of Psychopharmacology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 175600797
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice—from a human poisoning case to the preclinical evidence.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Bassi%2C+Marta%22">Bassi, Marta</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bilel%2C+Sabrine%22">Bilel, Sabrine</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tirri%2C+Micaela%22">Tirri, Micaela</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Corli%2C+Giorgia%22">Corli, Giorgia</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Di+Rosa%2C+Fabiana%22">Di Rosa, Fabiana</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gregori%2C+Adolfo%22">Gregori, Adolfo</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alkilany%2C+Alaaldin+M%2E%22">Alkilany, Alaaldin M.</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Rachid%2C+Ousama%22">Rachid, Ousama</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Roda%2C+Elisa%22">Roda, Elisa</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zauli%2C+Giorgio%22">Zauli, Giorgio</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Locatelli%2C+Carlo+Alessandro%22">Locatelli, Carlo Alessandro</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Marti%2C+Matteo%22">Marti, Matteo</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Psychopharmacology%22">Psychopharmacology</searchLink>. Mar2024, Vol. 241 Issue 3, p489-511. 23p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Tryptamine%22">Tryptamine</searchLink><br /><searchLink fieldCode="DE" term="%22Neural+inhibition%22">Neural inhibition</searchLink><br /><searchLink fieldCode="DE" term="%22Hallucinogenic+drugs%22">Hallucinogenic drugs</searchLink><br /><searchLink fieldCode="DE" term="%22Poisoning%22">Poisoning</searchLink><br /><searchLink fieldCode="DE" term="%22Psilocybin%22">Psilocybin</searchLink><br /><searchLink fieldCode="DE" term="%22Mice%22">Mice</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Rationale: The 5-methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT, known online as "Moxy") is a new psychedelic tryptamine first identified on Italian national territory in 2014. Its hallucinogen effects are broadly well-known; however, only few information is available regarding its pharmaco-toxicological effects. Objectives: Following the seizure of this new psychoactive substances by the Arm of Carabinieri and the occurrence of a human intoxication case, in the current study we had the aim to characterize the in vivo acute effects of systemic administration of 5-MeO-MiPT (0.01–30 mg/kg i.p.) on sensorimotor (visual, acoustic, and overall tactile) responses, thermoregulation, and stimulated motor activity (drag and accelerod test) in CD-1 male mice. We also evaluated variation on sensory gating (PPI, prepulse inhibition; 0.01–10 mg/kg i.p.) and on cardiorespiratory parameters (MouseOx and BP-2000; 30 mg/kg i.p.). Lastly, we investigated the in silico ADMET (absorption, distribution, metabolism, excretion, toxicity) profile of 5-MeO-MiPT compared to 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) and N,N-dimethyltryptamine (DMT). Results: This study demonstrates that 5-MeO-MiPT dose-dependently inhibits sensorimotor and PPI responses and, at high doses, induces impairment of the stimulated motor activity and cardiorespiratory changes in mice. In silico prediction shows that the 5-MeO-MiPT toxicokinetic profile shares similarities with 5-MeO-DIPT and DMT and highlights a cytochrome risk associated with this compound. Conclusions: Consumption of 5-MeO-MiPT can affect the ability to perform activities and pose a risk to human health status, as the correspondence between the effects induced in mice and the symptoms occurred in the intoxication case suggests. However, our findings suggest that 5-MeO-MiPT should not be excluded from research in the psychiatric therapy field. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Psychopharmacology is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=175600797
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00213-024-06526-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 23
        StartPage: 489
    Subjects:
      – SubjectFull: Tryptamine
        Type: general
      – SubjectFull: Neural inhibition
        Type: general
      – SubjectFull: Hallucinogenic drugs
        Type: general
      – SubjectFull: Poisoning
        Type: general
      – SubjectFull: Psilocybin
        Type: general
      – SubjectFull: Mice
        Type: general
    Titles:
      – TitleFull: Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice—from a human poisoning case to the preclinical evidence.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bassi, Marta
      – PersonEntity:
          Name:
            NameFull: Bilel, Sabrine
      – PersonEntity:
          Name:
            NameFull: Tirri, Micaela
      – PersonEntity:
          Name:
            NameFull: Corli, Giorgia
      – PersonEntity:
          Name:
            NameFull: Di Rosa, Fabiana
      – PersonEntity:
          Name:
            NameFull: Gregori, Adolfo
      – PersonEntity:
          Name:
            NameFull: Alkilany, Alaaldin M.
      – PersonEntity:
          Name:
            NameFull: Rachid, Ousama
      – PersonEntity:
          Name:
            NameFull: Roda, Elisa
      – PersonEntity:
          Name:
            NameFull: Zauli, Giorgio
      – PersonEntity:
          Name:
            NameFull: Locatelli, Carlo Alessandro
      – PersonEntity:
          Name:
            NameFull: Marti, Matteo
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: Mar2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 00333158
          Numbering:
            – Type: volume
              Value: 241
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Psychopharmacology
              Type: main
ResultId 1